This article contains online-exclusive supplemental material for Malik's article entitled, "Allogenic Versus Autologous Stem-Cell Therapy."
Jul 1, 2012
By:
Nafees Malik
This article contains online-exclusive supplemental material for Malik's article entitled, "Allogenic Versus Autologous Stem-Cell Therapy."
|
The author discusses potential manufacturing costs and commercialization challenges of allogeneic and autologous stem-cell therapy.
Jul 1, 2012
By:
Nafees Malik
The author discusses potential manufacturing costs & challenges of allogeneic & autologous stem-cell therapy.
|
Personalized medicines could become more popular than top earning drugs that face patent expiry
Dec 1, 2007
By:
Nafees Malik
Eighty drugs will lose patent protection between 2007 and 2011.
|
|